Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape

Immune checkpoint (IC) inhibition in glioblastoma (GBM) has not shown promising results in the last decade compared to other solid tumors. Several factors contributing to the lack of immunotherapy response include the profound immunosuppressive nature of GBM, highly redundant signaling pathways unde...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Julio F. Inocencio, Stefan Mitrasinovic, Mohammad Asad, Ian F. Parney, Xingxing Zang, Benjamin T. Himes
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	immune checkpoints glioblastoma immune microenvironment tumor immunosuppression immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1424396/full

Similar Items

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
by: Benjamin T. Himes, et al.
Published: (2021-10-01)

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01)

Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy
by: Niovi Nicolaou, et al.
Published: (2025-10-01)

Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01)

Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy
by: Catherine Yu, et al.
Published: (2023-12-01)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
by: Zihao Yan, et al.
Published: (2021-12-01)

Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01)

Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
by: Dongxin Jiang, et al.
Published: (2025-05-01)

Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
by: Shaoping Shen, et al.
Published: (2020-08-01)

Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma
by: Leiya Du, et al.
Published: (2024-08-01)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)

Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors in Treatment of Glioblastoma
by: LI Yingying, et al.
Published: (2022-05-01)

Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
by: Daniel Kreatsoulas, et al.
Published: (2022-06-01)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Hui Qiu, et al.
Published: (2021-09-01)

Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
by: Haitian Wang, et al.
Published: (2025-10-01)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
by: Feng Tang, et al.
Published: (2023-08-01)

Overcoming immune evasion with innovative multi-target approaches for glioblastoma
by: Hai Su, et al.
Published: (2025-01-01)

Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
by: Hao Zhang, et al.
Published: (2024-06-01)

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
by: Tingting Wang, et al.
Published: (2022-10-01)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022-05-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
by: Um‐e‐Kalsoom, et al.
Published: (2024-10-01)

Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
by: Xianzhe Yu, et al.
Published: (2023-04-01)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
by: Jingchang Zhang, et al.
Published: (2022-07-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Glioblastoma‐activated pericytes support tumor growth via immunosuppression
by: Isadora F. G. Sena, et al.
Published: (2018-04-01)

Glucocorticoids Downregulate PD-L1 in Glioblastoma Cells via GILZ-Mediated ERK Inhibition
by: Sabrina Adorisio, et al.
Published: (2025-07-01)

Immunotherapy against glioblastoma using backpack‐activated neutrophils
by: Tatsuya Fukuta, et al.
Published: (2025-01-01)

Microglia and macrophages in glioblastoma: landscapes and treatment directions
by: Georgios Solomou, et al.
Published: (2024-12-01)

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
by: Xiaohan Zhou, et al.
Published: (2021-07-01)

CAR-T treatment for cancer: prospects and challenges
by: Ran Chen, et al.
Published: (2023-12-01)

Immunotherapy: Advancing glioblastoma treatment—A narrative review of scientific studies
by: Sagun Tiwari, et al.
Published: (2024-02-01)

Tumor-Associated Macrophages in Glioblastoma: Mechanisms of Tumor Progression and Therapeutic Strategies
by: Jianan Chen, et al.
Published: (2025-09-01)

GPR65 as a potential immune checkpoint regulates the immune microenvironment according to pan-cancer analysis
by: Liangliang Wang, et al.
Published: (2023-02-01)

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
by: Karam Khaddour, et al.
Published: (2020-11-01)

Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints
by: Hanhui Jing, et al.
Published: (2025-06-01)

Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme
by: Luke C. Cooksey, et al.
Published: (2024-09-01)

Mitochondrial DNA transfer between malignant cells and T lymphocytes shapes the cancer-immunity dialogue
by: Liwei Zhao, et al.
Published: (2025-12-01)